Preventive Maintenance and unlimited repair agreement for a Thermo Fisher Q Exactive mass spectrometer, Base + 2 Option years

The FDA Office of Acquisition and Grant Services seeks preventive maintenance and unlimited repair services for a Thermo Fisher Q Exactive mass spectrometer, with quotes due May 13, 2026 by 3:30 PM Central Time. The procurement is a small business set-aside under NAICS code 811210 (Electronic and Precision Equipment Repair and Maintenance).

Place of performance is the FDA's Center for Biologics Evaluation and Research (CBER), Facility for Biotechnology Resources, located at 10903 New Hampshire Ave., Silver Spring, Maryland. The contract covers the instrument (Serial Number 02092P), its control computer, and associated software (Xcalibur and DCMSlink for Xcalibur).

The contractor must provide one scheduled on-site preventive maintenance visit annually with all labor, travel, and OEM-certified replacement parts included; unlimited on-site corrective maintenance and repairs within three business days of service call, with 24-hour priority response capability; use of OEM-certified parts and formally trained technicians; and unlimited priority technical support Monday through Friday, 7:00 AM to 5:00 PM Eastern Time. The contractor must also provide field service reports documenting work performed, technician information, and parts replaced, and must hold prices firm through September 30, 2026. Pricing must be all-inclusive of labor, travel, and replacement parts.

The base performance period runs July 31, 2026 to July 30, 2027, followed by two optional one-year periods through September 30, 2029. Evaluation criteria are technical capability, past performance with this specific instrument within the last three years, and price. The contractor must complete an Accessibility Conformance Report addressing Section 508 compliance, certify Service Contract Act exemption eligibility under FAR 52.222-48, and comply with Buy American requirements. Quotes should be sent to Suzanne Martella at suzanne.martella@fda.hhs.gov, referencing solicitation number 75F40126Q133878.